| 摘要 |
PROBLEM TO BE SOLVED: To provide a pharmaceutical composition for the treatment of tumors which express a somatostatin and/or dopamine receptor, such as neuroendocrine tumor, adenocarcinoma, brain tumor, or hematological malignancy.SOLUTION: A pharmaceutical composition comprises at least one demethylating agent such as 5-aza-2'-deoxycytidine, at least one dopamine agonist such as BIM23A765 and cabergoline, and at least one somatostatin analog such as BIM-23206, BIM-23926, and octreotide. |
